Consistent with a relevant pathological role for GRK2-medited changes in Pin1 acetylation status, GRK2 expression and Pin1 levels and de-acetylation status correlate in both cell models and in samples from breast cancer patients [111]. The gene discussed is PIN1; the disease is breast carcinoma.